THE INFLUENCE OF INTERLEUKIN (IL)-4, IL-13, AND FLT3 LIGAND ON HUMAN DENDRITIC CELL-DIFFERENTIATION FROM CORD-BLOOD CD34(+) PROGENITOR CELLS

Citation
M. Rosenzwajg et al., THE INFLUENCE OF INTERLEUKIN (IL)-4, IL-13, AND FLT3 LIGAND ON HUMAN DENDRITIC CELL-DIFFERENTIATION FROM CORD-BLOOD CD34(+) PROGENITOR CELLS, Experimental hematology, 26(1), 1998, pp. 63-72
Citations number
38
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
ISSN journal
0301472X
Volume
26
Issue
1
Year of publication
1998
Pages
63 - 72
Database
ISI
SICI code
0301-472X(1998)26:1<63:TIOI(I>2.0.ZU;2-Z
Abstract
Culturing cord blood CD34(+) cells with granulocyte-macrophage colony- stimulating factor (GM-CSF) and tumor necrosis factor (TNF)-alpha for 12 days, and stem cell factor (SCF) for 5 days, resulted in a 40- +/- 26-fold expansion in cell numbers, with 38 +/- 20% dendritic cells (DC s). Interleukin (IL)-4 and IL-13, which share properties, were examine d first. Adding either one to the former baseline condition beginning on day 0 halved cell growth while the percentage of DCs increased to 6 0-70%, resulting in unchanged DC yields. Delaying use of IL-4 or IL-13 to day 5 led to 25-fold cell expansion with approximately 80% DC, the yield of which was then twofold over that of baseline control culture s, while numbers of other cells decreased. IL-4 and IL-13 had no addit ive or antagonistic effect on DC generation. The effect of Flt3 ligand (FL), known to enhance proliferation of hematopoietic progenitors ind uced by other growth factors, was examined next. FL added alone induce d DC in the same manner as SCF. Using both FL and SCF throughout the c ulture period enhanced total cell recovery fourfold above that of base line control cultures on day 12 compared with greater than or equal to 2.5-fold if either one was stopped on day 5. When both FL and SCF wer e used for 12 days, DC recovery was fivefold that of control cultures, whereas it was to three-to 3.5-fold when either one was stopped on da y 5. A similar trend was noted for CD15(+) cells, and, to a lesser ext ent, for CD14(+) cells. Finally, using SCF and FL for 12 days, with IL -4 or IL-13 added from day 5 onwards, led to comparably enhanced cell yields relative to control cultures with approximately 60% DC. These d ata underline the need to use appropriate cytokine combinations and sc hedules to optimize generation of DCs from CD34(+) progenitors. Associ ated with GM-CSF and TNF-alpha, IL-4 or IL-13 promotes differentiation and maturation of DCs over other myeloid cells. Under the same baseli ne conditions, FL appears to potentiate SCF throughout the culture per iod, inducing proliferation and development of DC as well as of other myeloid cells.